As of 2024-12-12, the Relative Valuation of Erytech Pharma SA (ERYP.PA) is 0.06 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 EUR, the upside of Erytech Pharma SA based on Relative Valuation is -87.5%.
The range of the Relative Valuation is (0.08) - 0.38 EUR.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 14.9x | 10.0x |
| Forward P/E multiples | 15.7x - 33.3x | 18.2x |
| Fair Price | (0.08) - 0.38 | 0.06 |
| Upside | -115.9% - -23.1% | -87.5% |
| Date | P/E |